INTRODUCTION
Most patients with hypogammaglobulinemia have deficient or absent plasma cells in bone marrow, lymphoid tissue (1), and gut (2) . Such patients represent a variety of immunodeficiency states, in certain of which both cellmediated and humoral immune systems are involved (3) . Since the advent of methods permitting the identification of small lymphocyte subpopulations (4) , it has become possible to pinpoint a variety of defects in the development of the cells which comprise the humoral limb of the immune system (reviewed in 5). Patients with Bruton-type (infantile, X-linked) agammaglobulinemia seem to have a defect in the earliest stages of bone marrow-derived-(B) lymphocyte development, and generally lack cells clearly identifiable as B cells. Patients with thymoma and immunodeficiency also often seem to lack B cells. In one such patient, circulating cells were present which could differentiate in vitro into apparently normal B cells (6) . Some of these patients may therefore have a block at an intermediate stage of B-lymphocyte differentiation. A third pattern is seen in patients with the heterogeneous syndromes of common variable immunodeficiency. The cells of most of these patients seem capable of differentiating normally to the stage of mature B lymphocytes, but are unable in vivo to undergo significant terminal differentiation into secreting plasma cells (5, (7) (8) (9) 12) .
Reports of studies on the ability of the cells of various hypogammaglobulinemic patients to synthesize and secrete immunoglobulins (Ig) in vitro (10) , taken together with electronmicroscopic (11) or immunofluorescent (7, 8, 12 ) studies of terminal differentiation, indicate that the ability of a cell to produce and secrete large amounts of immunoglobulin is closely linked to morphologic differentiation into plasmacytoid cells. Such cells are characterized by the development of large amounts of rough endoplasmic reticulum and of cytoplasmic Ig.
Cells capable of suppressing various immunologic functions have been recently described in experimental animal systems (14) , and are thought to participate in the physiologic control of the immune response. in at least some patients, excess suppressor activity is a major pathogenetic mechanism of the immunodeficiency (12) .
We here report the finding of cell-dependent suppressor phenomena in patients having a variety of syndromes of impaired B-lymphocyte differentiation representing several steps along the pathway to the plasma cell.
METHODS
Patients investigated were selected from a clinic population of immunodeficient adults and children. Patients were chosen for study largely on the basis of availability for repeated analysis and a relatively well-defined disease, although certain patients were studied because they fell into specific categories (e.g., all available patients with Bruton-type agammaglobulinemia were examined). Patients were classified according to the recommendations of the Exipert Committee of the World Health Organization (15) . Base-line information on the patients is included in Table I . Normal blood donors and adult laboratory personnel served as controls.
Peripheral blood was heparinized (20 U/ml) under sterile conditions, diluted 1: 2 with physiologic saline, and separated on Ficoll-Hypaque according to Boyum (16) . Mononuclear cell fractions from normal subjects, as isolated in our laboratory, contain 10-50% (mean = 28%o) phagocytic (latex-in- The initial cell concentration in the cultures was adjusted on the basis of .the number of lymphocytes. Cells from differen;t subj ects were cultured separately or co-cultured in mixtures at varying ratios. Normal cells were co-cultured with other nornal cells under identical conditions.
In the early experiments, cultures were carried out in 30-ml plastic disposable flat-bottoomed culture flasks (Falcon Plastics, Division of BioQuest, Oxnard, Calif.), at volumes of 4-6 ml, initially containing 1 X 106 lymrphocytes/ml. When cell numbers were severely limited, and later, routinely, smaller volumes (1-3 ml) were cultured, usually at 1 X 106 cells/ml in plastic round-bottomed 15-cc test -tubes (Falcon Plastics). Because of geometrical considerations involved in the different culture systems, appropriate controls utilizing identical cell concentrations, volumes, and containers were always run when deviations from the flat-bottomed flasks were required. Because of limitations of available cell numbers, duplicate cultures were not run in all experiments, but were done whenever the initial cell yield permitted. Data from 19 sample paired identical cultures done during the series of experiments were statistically analyzed.
Cultures were terminated on day 7; the cells were counted with trypan blue to assess the absolute yield of viable cells from each culture, as trypan blue excluding cells per milliliter. No attempt was made at this time -to differentiate between lymphoid and nonlymphoid cells, but most of the cells recovered on slides and stained with tetrachrome appeared to be lymphoid. The cell's were then pelleted, and the cell pellets was washed once in bovine albumin (2 g/100 ml) in phosphatebuffered saline (PBS), and adjusted to an appropriate volume. Cytocentrifuge smears were prepared and stored frozen at -20°C. For immunofluorescent staining, slides were thawed, dessicated, fixed in 5% (vol/vol) glacial acetic acid in methanol at -20°C, washed three times in PBS, and stained with the antiglobulin reagent at room temperature for 30 min in a moist chamber. The slides were washed three times again in PBS, once in distilled water, and air dried.
The antiserum used in the present study was a mixture of two rabbit antisera, having combined specificities in Ouchterlony analysis for mu, gamma, kappa, and lambda determinants, prepar,ed as described previously (9) .
Microsoopy was carried out using a Leitz Orthoplan microscope (E. Leitz, Inc., Rockleigh, N. J.) equipped for fluorescence with a Ploem incident illuminator (9) .
Coded fluorescence-labeled slides were read by a single observer (Dr. F. P. Siegal). The code was broken only after the entire set of slides in a particular experiment had been read, to reduce the possibility of observer bias. A minimum of 1,000 cells was counted from each culture, recorded as paired counts of 500 or more cells.
For purposes of this study, cells were regarded as plasma cells if they had brightly stained cytoplasmic Ig. There was a wide morphologic spectrum of such cells; they were not morphologically distinct, other than in their fluorescence, from the negative cells in the same cultures. Some were large, clearly plasmacytoid cells with abundant cytoplasm and eccentric nuclei; others were more lymphoid. Generally, small lymphocytes were negative for Ig.
When viewed with rhodamine-specific illumination, negative cells gave a faint red glow; the cytoplasm of positive cells stained bright red, with a diffuse or slightly granular cytoplasmic fluorescence, and stood out in sharp contrast to the cell nucleus and to the background cells (Fig. 1) . Oc (17) . 1-ml aliquots of 5 X 106 mononuclear cells in HBSS were mixed with an equal volume of 0.5% washed sheep erythrocytes in 10%o heat-inactivated human AB serum previously absorbed with sheep red blood cells, in 15-ml round-bottomed plastic test tubes, incubated for 10 min at 37°C, pelleted for 10 min at 20 g, and kept at 4°C overnight. Unseparated cells from the same patient and from the normal donor were also held overnight at 4°C for appropriate controls. The rosetting mixtures were gently resuspended, layered over FicollHypaque, and centrifuged for 20 min at 400 g. The resulting pellets and interface cells were then pooled and washed several times before culture. Sheep erythrocytes were lysed by exposure to 0.83%o NH4Cl. A sampling of the efficiency of rosette formation after resuspension from such large volumes was compared with the 0.2-ml rosetting mixtures ordinarily used. This procedure left approximately 20-30o of the cells which would be expected to form rosettes in the nonrosetting fraction (interface). Many cells usually regarded as thymus-derived (T) lymphocytes were present in the interface fraction, which also contained a substantial proportion of monocytes.
To screen for serum-mediated inhibition of plasma cell generation, frozen sera from patients studied were inactivated at 56°C for 30 min. To normal lymphocytes cultured under the conditions described in 2 ml of culture medium with 20% FCS, was added 0.2 ml of the inactivated serum.
Pooled human AB serum, serum from random normal adult laboratory workers, and additional FCS were used as negative controls. Table I ). Yields of viable cells after 7 days of culture were similar for patients (110.1%, 
Reproducibility of the method
The relatively simple approach used in this study was evaluated for its reproducibility and found to be quite reliable. Analysis of the 19 duplicate culture pairs showed that the deviation from the mean of paired cultures was no more than that expected from a Poisson distribution, as was the counting error in paired counts of 500 cells each from a given culture. Most of the normal control samples were from blood bank donors, who could not be studied repeatedly. The proportion of plasmacytoid cells found at the termination of these cultures varied considerably (see above). Mixed culture, normals Co-culture of cells from pairs of normal donors led to plasma cell generation at both 1: 1 and 1: 2 cell ratios (donor 1: donor 2). The overall proportion of plasma cells found in the mixed cultures of normals was slightly greater than would have been expected from dilutional factors alone (Fig. 3) . In 11 co-cultures, at 1: 1 cell mixtures, the ratio of plasma cells found to those predicted by mixing alone (F/P value) was 1.16±0. 24 (1 SD). The lowest F/P value found for an individual coculture of normals was 0.88±0.18. At donor cell ratios of 1 : 2, the mean F/P value was also above unity (1.07+0.61, 1 SD), but some lower values were encountered, the range being from 0.40 to 1.59 (Fig. 4) .
Mixed culture, hypogammaglobulinemic states Common variable immunodeficiency (Fig. 5 ). The cells of eight of these patients co-cultured with normal cells showed low F/P ratios in 9/11 trials. All patients demonstrated some degree of suppressor activity. In two trials, the normal control alone generated fewer than 15-20 plasma cells/1,000 cells recovered. Under these conditions, the statistical significance of an apparent enhancement of plasma cell generation could not be assessed; the possible biological significance of these results remains in doubt. In all cases in which statistically adequate numbers of plasma cells were generated by the normal, suppression occurred. An F/P value 2 SD below the mean F/P value for co-cultures of normal cells (less than 0.68 for starting cell ratios of 1: 1) was regarded as showing suppression. Bruton-type agammaglobulinemia. Five of six patients with this diagnosis showed clear-cut suppressor activity at 1: 1 starting ratios of patient: normal cells (Table II) . Repeated analysis with one such patient (Ma) mixed with different normal cells at times showed suppressor activity at 1: 1 ratios, but at times did not. On one occasion when there was no demonstrable effect at 1: 1, suppression was observable in the mixtures which contained patient: normal cells in a 2: 1 ratio. This is discussed further below.
The cells of one patient (Ar), whose younger brother was also affected but was not studied, appeared to enhance the production of plasma cells in vitro (F/P value 2.1). This result was reproducible over several cell ratios with the normal control (Table II) , all below 1:1 (patient: normal). A patient-normal cell ratio of 2: 1 was not tested, because of the paucity of patient cells. This was the only such result in the series in which the normal cells alone produced sufficient numbers of plasma cells to permit an apparent enhancement to be considered significant (see above). (1 SD).
ratios. The second normal, the patient's HLA-identical, mixed-leukocyte culture-matched twin brother, was also suppressed, but only at starting cell ratios of 2: 1 (Fig.  6 ).
Effect of varying the ratio of patient: normal cells
Mononuclear cells from hypo-or agammaglobulinemic patients were co-cultured with normal mononuclear cells at starting ratios varying from 1: 9 to 2: 1 (patient: normal). Although most conveniently depicted in patients with Bruton-type agammaglobulinemia (Fig. 7) , the results were similar in all categories in immunodeficiency studied. The greater the ratio of patient: normal cells, the greater was the degree of suppression observed. At 1: 1 ratios, the patient-normal mixed cultures were significantly different from the normal-normal cultures (P < 0.001). The cells of certain normals cocultured at ratios other than 1: 1 gave F/P values considerably below 1, while others were above that ideal value. Co-cultures of hypogammaglobulinemic cells of all types at 2: 1 ratios with cells from normals usually gave F/P values lower than those seen for any of the normal co-cultures. These differences between normal cells co-cultured at 2: 1 ratios and normals co-cultured with hypogammaglobulinemic cells at 2: 1 were also highly significant (P < 0.001) (Fig. 8) . Moreover, the five patients whose F/P values at 1: 1 ratios were normal or borderline low all fell below any of the normal co-cultures when their cells were co-cultured at 2: 1. Certain hypogammaglobulinemic cells were apparently suppressive at ratios of patient: normal well below 1: 1; thus, the cells of two patients with Bruton-type agammaglobulinemia (Fig. 7) Patient Ma, with Bruton-type agammaglobulinemia, was studied in this way on three occasions in combination with different normal control subjects. In set one (Table III) , the Ficoll-Hypaque mononuclear cells which contained 40% NLC did not suppress at 1: 1 ratios, but at 2: 1 there was inhibition (F/P value, 0.33). Nylon column passage yielded three fractions depleted of adherent cells to varying degrees, which were devoid of suppressing effects and of which two appeared to give significant enhancement to the net production of plasma cells. In set 2, Table III It was important to determine how frequently and with what significance those events occurred in patients with CVI, and whether suppressor-like activity could be detected in other primary hypogammaglobulinemias. The results of the present study confirm that in vitro suppression of terminal differentiation of B lymphocytes can be produced with cells from patients with CVI. These studies also show that similar suppression occurs in patients with a variety of other hypogammaglobulinemic states of obviously differing pathogenetic mechanisms. This finding indicates that the mere demonstration of suppressor activity does not signify its importance in the pathogenesis of the disorder in which it is found.
In an experimental model, suppression seemed to be (20, 21) experiments in which chickens rendered agammaglobulinemic by bursectomy and irradiation ultimately develop cells which, on transfer to otherwise normal birds of the same inbred strain, reduce circulating gamma globulin levels in the recipients. In this model, removal of the source of B cells (the bursa of Fabricius) and irradiation (to kill perpiheralized B cells) not only leads to agammaglobulinemia, but also, eventually, to the development of cells which suppress immunoglobulin synthesis in other birds. Here the suppressor population develops as a consequence of B-cell deficiency.
The experimental system in the present studies takes advantage of the ability of PWM to drive fully-formed B lymphocytes to differentiate into plasma cells (7, 8, 11, 12) . When cultured with this agent, cells of most of our hypogammaglobulinemic subjects were distinguished from normal cells by their almost complete inability to undergo those final differentiative steps. Wu et al. (7), Waldmann et al. (12) , and Geha et al. (13) have made similar observations, although a later publication of Wu et al. (8) suggests this may not be universally true of such patients. One of our patients (Ro), whose father (not studied) had selective IgA deficiency, did make normal numbers of plasmacytoid cells on two of three occasions, and always produced some stainable cells. Interestingly, even this patient showed some suppressor activity on two occasions.
Cells from patients with Bruton-type agammaglobulinemia (presumably X-linked agammaglobulinemia) and thymoma with immunodeficiency produced suppressive effects similar to those observed with cells from patients with CVI.
The prototype of the suppression originally described by Waldmann is seen in patients with CVI. Most such patients have B cells that have developed to cells with surface markers identical to those of normal individuals. Such cells have apparently normal amounts of intrinsic surface Ig (IgM, IgD) as detected by immunofluorescence, indicating the ability of these patients to synthesize the immunoglobulin molecules and insert them into the cell membranes (5, 9, 13, 15, 22) . The B cells of many of these patients had, before Waldmann's observation, usually been considered to be functionally incapable of undergoing further differentiation into secreting cells (7) . Biochemical studies led to similar conclusions (10) . All eight patients in this series having a diagnosis of CVI had B cells in normal numbers (defined by the presence of IgM-and IgD-bearing lymphocytes). All exhibited at least some capacity to suppress PWMdriven terminal differentiation when co-cultured with cells from normal persons. Manipulations designed to remove suppressing cells either by rosetting or by adherence to nylon wool columns did permit terminal differentiation in the cells of one patient tested. The several failures may have been attributable to technical difficulties as yet undefined, such as incomplete removal of suppressors. However, the unsuccessful experiments were notable for their more efficient separation of B and T cells and by their better recoveries. Another possibility is that more efficient separations removed helper cells involved in plasma cell production. The results may indicate that suppressor cells, found even in CVI, are not always pathogenic. Our findings suggest that B cells of some but not other patients with CVI can differentiate to plasma cells in the absence of suppressors. Those patients who cells cannot so differentiate would need be considered to have either intrinsic cellular defects or other factors of the internal milieu which prevent terminal differentiation. The application of these new criteria reveals, in still another way, that CVI is a variable group of diseases very likely based on different mechanisms.
The finding of excess suppressor cell activity in the patients with Bruton's agammaglobulinemia initially was surprising. Unlike CVI, this disease is characterized usually by a lack of B lymphocytes in peripheral blood and lack of germinal centers in stimulated lymphoid tissue. While a few patients having this diagnosis seem to have cells carrying IgM or other immunoglobulin classes, most do not (3, 5, 6, 9, 22) . A proportion of the cells which circulate in these patients carry other markers found on B cells (Fc receptors, complement receptors, lack of sheep-rosetting capacity); it remains uncertain whether the latter are B cells incapable of developing surface and intracytoplasmic Ig, though equipped with the structural gene (5) for Ig synthesis, or whether they represent a third population of lymphoid cells (6, 22 An alternative, and perhaps better, hypothesis is that the suppressor activity observed in the patients with Bruton's agammaglobulinemia is similar to that seen in the chicken model of Blaese et al. discussed above (20) . In this interpretation, a genetically determined defect of B-cell differentiation would lead to generation of a suppressor population of cells. That this is the case is suggested by the failure of the cells of such patients to generate plasma cells in culture after removal on nylon columns of cells suppressing terminal differentiation. In one case, plasma cells were not found despite the fact that the remaining nonadherent cells actually seemed to enhance plasma cell generation by normal cells in mixed culture.
The pathogenesis of the thymoma-agammaglobulinemia syndrome is not well understood. In the patient studied here as well as in other patients (6), cells which carry intrinsic surface Ig have been absent, although precursors of such cells may circulate (6) . The finding of suppressors in such patients, as also recently reported by Waldmann et al. (23) , lends additional weight to the doubts about the primary role of the suppressors, by arguments similar to those expressed above. Cells involved in suppression may be heterogeneous. In certain patients, removal of nylon-adherent cells removed the suppressive effects on normal lymphocytes, and indeed revealed enhancement of plasma cell formation in those mixed cultures. The cells of one patient with Bruton's agammaglobulinemia and one with CVI exhibited such enhancing influences. Passage of the latter's cells through a nylon column permitted generation of a few plasma cells among the cells cultured from column effluents. These data indicate that an adherent cell participates in the suppressor effects. Since moncytes are a major class of adherent cells, attempts were made to restore suppression by adding back the monocytes. In one experiment, a column eluate containing 46% monocytes failed to suppress plasma cell morphogenesis, although the unseparated cells had been suppressive. Moreover, effective removal of monocytes by nylon columns from the suppressive cells of other patients to as few as 0.5% did not remove suppressor activity.
These results suggest that it is not the monocytes themselves which are suppressing plasma cell formation in these patients. The recovery of lymphocytes from the nylon columns was only 60-70%. Lymphoid as well as monocytoid cells were removed by adherence to the column. There may have been selective loss of a functionally suppressive subpopulation of lymphocytes. If the suppressors lost on the nylon columns were, indeed, lymphocytes, the proportion of monocytes might merely be a measure of the effectiveness of the adherence column in removing adherent cells. Because adherence columns have been found by Folch and Waksman to remove cells apparently suppressing lymphocyte mitogenic responses as measured by incorporation of tritiated thymidine, these workers postulated that a monocyte/T-cell complex might be involved in certain forms of suppression (24) .
Cells spontaneously forming rosettes with sheep erythrocytes (presumably T cells) seem to be implicated as suppressors in at least one of our patients (Co), as in one of the cases reported by Waldmann et al. (12) . When Co's rosetting cells were separated from nonrosette-forming cells, the rosetting cells continued to show some suppressor activity, although a net loss of suppressors during the separation appears to have occurred. The nonrosetting cells, as well as some cells carried down into the rosetting fraction, seemed released to generate plasma cells when cultured alone. The patient in which these differential effects were seen was the same patient in whom removal of adherent cells permitted terminal differentiation to plasma cells. This finding would suggest that either adherent T The mechanism of the suppressing event observed needs to be further defined. Humoral mediators have been reported to be suppressive. Sera of our patients were not suppressive. This does not rule out the possibility that a humoral mechanism (rather than cell to cell contact) is involved. The lack of serum inhibition reduces the possibility that small amounts of serum factors carried over with the washed mononuclear cells were actually responsible for suppression in the system studied. Supernates of the suppressing cultures are being investigated to assess their effects in vitro.
In most of these experiments, the viability of cells was essentially the same when normal cells or cells of immunodeficient patients were cultured alone or together in the several possible combinations. Co-cultures in which plasma cell generation was severely suppressed possessed as many viable cells as did co-cultures in which no suppression was observed. The results cannot be explained by a generalized "toxic" effect on the cultures, although a selective (antiproliferative?) effect on B cells (pres-ent at about 5% in the starting cultures) could account for the results.
Allogeneic interactions in vitro do not appear to play a significant role in the suppressor phenomena observed, for several reasons. First, autologous suppression seems a reality, since it could be removed and reveal, as in Co, the ability of the patient's own cells to differentiate. Second, some suppression was observed between hypogammaglobulinemic and normal members of an identical twin pair (Ka). Third, mixed-lymphocyte culture-reactive normals failed to suppress one another; while there may be some individual exceptions to this, overall, the allogeneic effects between normals appeared to enhance plasmacytoid cell production in this system (F/P ratios greater than 1.0).
An interesting speculation concerns the role of PWM in generating the suppressor cell activity. In these studies, we added PWM to evaluate the development of plasma cells. It is possible that PWM activated suppressors present in these patients' cells. Similar effects are induced by concanavalin A in a murine plaque-forming cell assay (25) . Such in vitro events could conceivably mimic the constant exposure to antigens of a wide range of specificities which could activate abnormally susceptible or populous cells in certain people, which would then produce a general tolerance-like state and lead, ultimately, to agammaglobulinemia. In others, the imbalance created by immunodeficiency might select for cells more likely to respond to this kind of activation.
Another question that must be raised is whether the suppressor cells observed in these patients are selectively affecting B cells, or whether they suppress T-cell functions and (or) other cell populations as well. The clinical data seem to indicate that in most of these cases, suppression is selective for B-cell differentiation. T-cell proliferation in response to PWM and other mitogens was apparently unaffected in most patients. Furthermore, many of the patients who showed severe degrees of plasma cell suppression have apparently normal cellmediated immunity both in vivo and in vitro.
The potential for clinical application of the information gained from investigation of suppressor cells in man is great. Definition of the role of suppressors in individual patients with immunodeficiency seems necessary if appropriate therapy is to be identified. For the treatment of patients with significant suppressor activity, methods need to be developed which will selectively remove it or render it nonfunctional. Perhaps adherence to nylon wool in a cell separator, or pharmacologic or serologic techniques can be used. In other patients, such efforts might be unsuccessful, when the defect is intrinsic to the B cell, and the suppressor population represents a secondary development. Rational therapy and a basic understanding of these disorders depends upon patient-by-patient dissection of the defects pathogenetic in the immunodeficiency disease.
Addendum. Since original submission of this paper, a report has appeared confirming the existence of suppressor cells in some patients with CVI (cultured at 1: 1 ratios), and finding, as we did, reduced or absent plasma cell generation in most patients with this form of immunodeficiency (26) .
